GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Monash IVF Group Ltd (ASX:MVF) » Definitions » EV-to-Revenue

Monash IVF Group (ASX:MVF) EV-to-Revenue

: 2.95 (As of Today)
View and export this data going back to 2014. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Monash IVF Group's enterprise value is A$696.4 Mil. Monash IVF Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$236.0 Mil. Therefore, Monash IVF Group's EV-to-Revenue for today is 2.95.

The historical rank and industry rank for Monash IVF Group's EV-to-Revenue or its related term are showing as below:

ASX:MVF' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.2   Med: 2.48   Max: 4.32
Current: 2.96

During the past 10 years, the highest EV-to-Revenue of Monash IVF Group was 4.32. The lowest was 1.20. And the median was 2.48.

ASX:MVF's EV-to-Revenue is ranked better than
50.66% of 227 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.03 vs ASX:MVF: 2.96

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-23), Monash IVF Group's stock price is A$1.49. Monash IVF Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.61. Therefore, Monash IVF Group's PS Ratio for today is 2.46.


Monash IVF Group EV-to-Revenue Historical Data

The historical data trend for Monash IVF Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monash IVF Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-Revenue
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.71 1.73 2.02 2.28 2.53

Monash IVF Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.28 - 2.53 -

Competitive Comparison

For the Diagnostics & Research subindustry, Monash IVF Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Monash IVF Group EV-to-Revenue Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Monash IVF Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Monash IVF Group's EV-to-Revenue falls into.



Monash IVF Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Monash IVF Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=696.369/235.971
=2.95

Monash IVF Group's current Enterprise Value is A$696.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Monash IVF Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$236.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Monash IVF Group  (ASX:MVF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Monash IVF Group's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.49/0.606
=2.46

Monash IVF Group's share price for today is A$1.49.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was A$0.61.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Monash IVF Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Monash IVF Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Monash IVF Group (ASX:MVF) Business Description

Traded in Other Exchanges
Address
510 Church Street, Level 1, Cremorne, Cremorne, VIC, AUS, 3121
Monash IVF Group Ltd is a specialist assisted reproductive services provider. The company offers specialist diagnostic obstetric and gynaecological ultrasound and fertility treatments. The company's operating segment includes Australia and International. It generates maximum revenue from the Australian segment. Australian segment is a provider of Assisted Reproductive Services, Ultrasound, and other related services. The International segment is a provider of Assisted Reproductive Services in Malaysia.